-
Why biotech will command the headlines this year
Features Big pharmaceutical companies need to develop new drugs to survive - but they are cutting back on essential research. That opens the way for small biotech companies to fill the gaps, says Tom Bulford. Here, he examines the industry's potential.
Features -
The biotech firm that soared in value nineteen-fold
Features Biotech is a sector on the cusp of a thrilling revival. Tom Bulford looks at several biotech shares including one that's seen its share price rise nineteen fold in just three days.
Features -
Three biotech penny shares to watch
Features Diabetes is on the rise. Companies working to counter its effects stand to make big profits. Here, Tom Bulford looks at three small-cap biotech companies aiming to do just that.
Features -
Four experimental biotech stocks
Features The field of 'regenerative medicine' has seen some incredible advances, and the market is set to take off, says Marc Lichtenfeld. Here, he explains how to play the sector and tips four potential winners.
Features